Structure Therapeutics Inc. financial data

Symbol
GPCR on Nasdaq
Location
611 Gateway Blvd Suite 223, South San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.39K % +5.09%
Debt-to-equity 4.8 % -9.43%
Return On Equity -21.3 % -5.92%
Return On Assets -20.3 % -6.44%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 173M shares +0.7%
Common Stock, Shares, Outstanding 173M shares +0.65%
Common Stock, Value, Issued 17K USD 0%
Weighted Average Number of Shares Outstanding, Basic 173M shares +16.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 164M USD +104%
General and Administrative Expense 56M USD +32.7%
Operating Income (Loss) -220M USD -79.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -178M USD -78%
Income Tax Expense (Benefit) 465K USD +166%
Net Income (Loss) Attributable to Parent -179M USD -78.2%
Earnings Per Share, Basic -1 USD/shares -42.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 147M USD -61.5%
Cash, Cash Equivalents, and Short-term Investments 787M USD -15.2%
Assets, Current 799M USD -14.8%
Property, Plant and Equipment, Net 3.46M USD +4.34%
Operating Lease, Right-of-Use Asset 7.48M USD +75.4%
Other Assets, Noncurrent 6.2M USD +240%
Assets 816M USD -13.8%
Accounts Payable, Current 8.99M USD +307%
Employee-related Liabilities, Current 5.59M USD +39.6%
Liabilities, Current 39M USD +72.3%
Operating Lease, Liability, Noncurrent 5.01M USD +64.6%
Other Liabilities, Noncurrent 317K USD +8.19%
Liabilities 44.4M USD +70.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 362K USD
Retained Earnings (Accumulated Deficit) -438M USD -69.2%
Stockholders' Equity Attributable to Parent 772M USD -16.2%
Liabilities and Equity 816M USD -13.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 173M shares +0.65%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 147M USD -61.5%
Operating Lease, Liability 7.68M USD +64.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -178M USD -77.2%
Lessee, Operating Lease, Liability, to be Paid 8.65M USD +67.6%
Operating Lease, Liability, Current 2.66M USD +63.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.72M USD -8.95%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.21M USD +66.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 970K USD +99.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.27M USD +234%
Preferred Stock, Shares Authorized 100M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 938K USD
Additional Paid in Capital 1.21B USD +2.47%
Share-based Payment Arrangement, Expense 25.3M USD +132%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%